UBS Upgrades UnitedHealth Group to Buy, Announces $640 Price Target
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Kevin Caliendo has upgraded UnitedHealth Group (NYSE:UNH) from Neutral to Buy and announced a price target of $640.
October 16, 2023 | 10:19 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
UnitedHealth Group has been upgraded from Neutral to Buy by UBS with a new price target of $640.
The upgrade from UBS is a positive signal for UnitedHealth Group. The new Buy rating and the high price target of $640 suggest that the analyst sees significant upside potential in the stock. This could lead to increased investor interest and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100